92 related articles for article (PubMed ID: 8099562)
21. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
[TBL] [Abstract][Full Text] [Related]
22. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit.
Hanania T; Hillman GR; Johnson KM
Synapse; 1999 Mar; 31(3):229-39. PubMed ID: 10029241
[TBL] [Abstract][Full Text] [Related]
24. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
Adams BW; Bradberry CW; Moghaddam B
Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
[TBL] [Abstract][Full Text] [Related]
25. Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure.
Ali SF; Holson RR; Newport GD; Slikker W; Bowyer JF
Brain Res Dev Brain Res; 1993 May; 73(1):25-33. PubMed ID: 7685665
[TBL] [Abstract][Full Text] [Related]
26. Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure.
Wang X; Gu Z; Zhong P; Chen G; Feng J; Yan Z
Mol Cell Neurosci; 2006 Jan; 31(1):15-25. PubMed ID: 16198123
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of N-methyl-D-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons.
Wang C; Kaufmann JA; Sanchez-Ross MG; Johnson KM
J Pharmacol Exp Ther; 2000 Jul; 294(1):287-95. PubMed ID: 10871324
[TBL] [Abstract][Full Text] [Related]
28. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
29. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.
Nishijima K; Kashiwa A; Hashimoto A; Iwama H; Umino A; Nishikawa T
Synapse; 1996 Apr; 22(4):304-12. PubMed ID: 8867025
[TBL] [Abstract][Full Text] [Related]
31. [Phencyclidine, a drug which induces psychosis: its neuropharmacological actions].
Nabeshima T; Furukawa H; Kameyama T
Yakubutsu Seishin Kodo; 1984 Sep; 4(2):133-47. PubMed ID: 6395556
[TBL] [Abstract][Full Text] [Related]
32. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
Schwabe K; Brosda J; Wegener N; Koch M
Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat.
Anastasio NC; Johnson KM
J Neurochem; 2008 Mar; 104(5):1210-8. PubMed ID: 17995927
[TBL] [Abstract][Full Text] [Related]
34. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
[TBL] [Abstract][Full Text] [Related]
35. Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine, and MK-801.
Mele A; Fontana D; Pert A
Synapse; 1997 Jul; 26(3):218-24. PubMed ID: 9183811
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
37. [Antagonistic effect of phencyclidine on cerebral ischemic damage of rats].
Bao WL; Sun FY; Tong JF; Zhang LM; Zhang AZ
Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):348-51. PubMed ID: 1725469
[TBL] [Abstract][Full Text] [Related]
38. Candidate mechanisms underlying phencyclidine-induced psychosis: an electrophysiological behavioral, and biochemical study.
Marwaha J
Biol Psychiatry; 1982 Feb; 17(2):155-98. PubMed ID: 6122473
[TBL] [Abstract][Full Text] [Related]
39. In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus.
Gerhardt GA; Pang K; Rose GM
J Pharmacol Exp Ther; 1987 May; 241(2):714-21. PubMed ID: 2883304
[TBL] [Abstract][Full Text] [Related]
40. Effects of phencyclidine on contractile forces of isolated rabbit papillary muscles.
Dai JL; Xu SF
Zhongguo Yao Li Xue Bao; 1991 Mar; 12(2):131-4. PubMed ID: 1776476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
